Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-16,017
Closed -$143K 191
2025
Q2
$143K Hold
16,017
0.04% 180
2025
Q1
$140K Buy
+16,017
New +$168K 0.04% 174
2023
Q4
Sell
-19,966
Closed -$197K 164
2023
Q3
$197K Hold
19,966
0.07% 138
2023
Q2
$210K Hold
19,966
0.07% 139
2023
Q1
$186K Sell
19,966
-8,047
-29% -$89.2K 0.06% 141
2022
Q4
$312K Sell
28,013
-186
-0.7% -$1.94K 0.11% 123
2022
Q3
$240K Hold
28,199
0.09% 130
2022
Q2
$295K Sell
28,199
-8,900
-24% -$97.6K 0.12% 127
2022
Q1
$404K Sell
37,099
-16,200
-30% -$213K 0.15% 116
2021
Q4
$721K Buy
53,299
+2,550
+5% +$34.1K 0.26% 80
2021
Q3
$688K Sell
50,749
-74
-0.1% -$1.05K 0.28% 75
2021
Q2
$726K Hold
50,823
0.3% 77
2021
Q1
$710K Buy
50,823
+14,888
+41% +$243K 0.32% 74
2020
Q4
$673K Buy
+35,935
New +$586K 0.32% 74

Other funds holding VTRS

Searle & Co's VTRS Position: Q3 2025 in Review

Searle & Co sold out of Viatris (VTRS) in Q3 2025, closing a stake of 16,017 shares — an estimated $143K sold.

Searle & Co first reported a position in VTRS in Q4 2020 and held it in 14 quarters. The position peaked at $726K in Q2 2021. 968 funds tracked by Wall St. Rank hold VTRS as of Q3 2025.

  • Searle & Co reported no remaining Viatris position as of Q3 2025 after selling out during the quarter.
  • Searle & Co sold 16,017 Viatris shares in Q3 2025, an estimated $143K.
  • Searle & Co first reported a position in Viatris in Q4 2020 and held it in 14 quarters.
  • Searle & Co's Viatris position peaked at $726K in Q2 2021.
  • 968 funds tracked by Wall St. Rank held Viatris as of Q3 2025.

Based on Searle & Co's 13F filing for Q3 2025, filed 4 Nov 2025.